South San Francisco, CA — November 26, 2018 — Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved ACTPen™ 162 mg/0.9 mL, a single-dose prefilled autoinjector for Actemra…Original Article
FDA Approves The ACTpen for Actemra, A Single-Dose, Prefilled Autoinjector
